Why CervoMed (CRVO) Is Advancing Today
After meeting with CRVO's management and analyzing its recent drug trial results, Boral believes that the company can improve the performance of its neflamapimod drug by using a higher dose of 80 milligrams...
Cervomed Inc. (CRVO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.16 | 1,000 | Officer | 1,267 | 2024-08-27 | Filing | |
| $0.61 | 32,786 | Director | 32,786 | 2021-05-13 | Filing | |
| $0.66 | 14,000 | Officer, Director | 14,000 | 2020-11-16 | Filing | |
| $0.63 | 5,000 | Officer | 15,000 | 2020-11-17 | Filing | |
| $0.67 | 10,000 | Officer | 10,000 | 2020-11-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 36 | Large Shareholder, Director | 840,451 | 2024-02-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Billionaire Hedge Funds
